Authors: Feleszko, W Mlynarczuk, I Nowis, D

Citation: W. Feleszko et al., In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor, FEBS LETTER, 503(2-3), 2001, pp. 219-220

Authors: Wojcik, C Bury, M Stoklosa, T Giermasz, A Feleszko, W Mlynarczuk, I Pleban, E Basak, G Omura, S Jakobisiak, M

Citation: C. Wojcik et al., Lovastatin and simvastatin are modulators of the proteasome, INT J BIO C, 32(9), 2000, pp. 957-965

Authors: Feleszko, W Mlynarczuk, I Balkowiec-Iskra, EZ Czajka, A Switaj, T Stoklosa, T Giermasz, A Jakobisiak, M

Citation: W. Feleszko et al., Lovastatin potentiates antitumor activity and attenuates cardiotoxicity ofdoxorubicin in three tumor models in mice, CLIN CANC R, 6(5), 2000, pp. 2044-2052

Authors: Feleszko, W Jakobisiak, M

Citation: W. Feleszko et M. Jakobisiak, Correspondence re: B. Agarwal et al., lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin. Cancer Res., 5:: 2223-2229, 1999., CLIN CANC R, 6(3), 2000, pp. 1198-1198

Authors: Golab, J Wilczynski, G Zagozdzon, R Stoklosa, T Dabrowska, A Rybczynska, J Wasik, M Machaj, E Oldak, T Kozar, K Kaminski, R Giermasz, A Czajka, A Lasek, W Feleszko, W Jakobisiak, M

Citation: J. Golab et al., Potentiation of the anti-tumour effects of Photofrin (R)-based photodynamic therapy by localized treatment with G-CSF, BR J CANC, 82(8), 2000, pp. 1485-1491

Authors: Feleszko, W Balkowiec, EZ Sieberth, E Marczak, M Dabrowska, A Giermasz, A Czajka, A Jakobisiak, M

Citation: W. Feleszko et al., Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis, INT J CANC, 81(4), 1999, pp. 560-567